Total Payments
$740.01
2024 Payments
$14.32
Companies
4
Transactions
33
Medicare Patients
5,271
Medicare Billing
$429,243
Payment Breakdown by Category
Food & Beverage$740.01 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $740.01 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $464.17 | 15 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $215.06 | 14 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $43.72 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $17.06 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.32 | 1 | AstraZeneca Pharmaceuticals LP ($14.32) |
| 2023 | $29.40 | 2 | AstraZeneca Pharmaceuticals LP ($29.40) |
| 2022 | $27.60 | 2 | Novo Nordisk Inc ($27.60) |
| 2021 | $143.96 | 6 | Novo Nordisk Inc ($143.96) |
| 2020 | $174.71 | 5 | Novo Nordisk Inc ($130.27) |
| 2019 | $61.53 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($61.53) |
| 2018 | $242.92 | 10 | Novo Nordisk Inc ($128.81) |
| 2017 | $45.57 | 3 | Novo Nordisk Inc ($33.53) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Respiratory | ||||||
| 11/28/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Respiratory | ||||||
| 06/09/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Respiratory | ||||||
| 11/30/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Diabetes | ||||||
| 06/20/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Diabetes | ||||||
| 10/05/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: Diabetes | ||||||
| 09/08/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: Diabetes | ||||||
| 07/30/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: Diabetes | ||||||
| 07/21/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $1.37 | General |
| Category: Diabetes | ||||||
| 06/03/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 05/26/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: Diabetes | ||||||
| 09/29/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 09/24/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: Diabetes | ||||||
| 02/11/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, COMBIVENT RESPIMAT | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: RESPIRATORY | ||||||
| 01/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, COMBIVENT RESPIMAT | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: Diabetes | ||||||
| 10/09/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,391 | 1,765 | $270,530 | $122,265 |
| 2022 | 18 | 1,364 | 1,747 | $228,410 | $113,004 |
| 2021 | 16 | 1,280 | 1,604 | $216,745 | $109,422 |
| 2020 | 20 | 1,236 | 1,569 | $200,345 | $84,552 |
Total Patients
5,271
Total Services
6,685
Medicare Billing
$429,243
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 441 | $93,825 | $35,965 | 38.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 229 | 229 | $43,900 | $28,707 | 65.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 208 | 295 | $43,580 | $17,306 | 39.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 113 | 113 | $11,300 | $8,125 | 71.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 42 | $11,925 | $5,596 | 46.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 24 | $10,120 | $4,952 | 48.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 13 | $7,290 | $3,678 | 50.4% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 36 | 38 | $13,680 | $3,567 | 26.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 115 | 115 | $6,475 | $3,387 | 52.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 55 | 56 | $8,400 | $2,816 | 33.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $4,720 | $2,575 | 54.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 150 | 241 | $3,510 | $2,024 | 57.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $2,940 | $1,570 | 53.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 26 | $1,305 | $765.70 | 58.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 57 | 59 | $4,215 | $534.72 | 12.7% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 11 | 12 | $1,200 | $412.68 | 34.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 22 | $1,430 | $229.11 | 16.0% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 11 | 11 | $715.00 | $55.70 | 7.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 276 | 424 | $86,920 | $34,016 | 39.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 233 | 233 | $37,280 | $30,048 | 80.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 206 | 288 | $40,320 | $18,552 | 46.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 115 | 119 | $11,850 | $8,114 | 68.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 20 | 24 | $7,800 | $5,186 | 66.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 120 | 124 | $5,580 | $3,512 | 62.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 17 | 17 | $5,015 | $2,807 | 56.0% |
About Amy Gourniak
Amy Gourniak is a Family Medicine healthcare provider based in Schnecksville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861502262.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Gourniak has received a total of $740.01 in payments from pharmaceutical and medical device companies, with $14.32 received in 2024. These payments were reported across 33 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($740.01).
As a Medicare-enrolled provider, Gourniak has provided services to 5,271 Medicare beneficiaries, totaling 6,685 services with total Medicare billing of $429,243. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Schnecksville, PA
- Active Since 08/30/2006
- Last Updated 08/15/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1861502262
Products in Payments
- Ozempic (Drug) $278.23
- STIOLTO RESPIMAT (Drug) $173.61
- RYBELSUS (Drug) $133.62
- Victoza (Drug) $33.53
- SPIRIVA RESPIMAT (Drug) $29.41
- BREZTRI (Drug) $29.40
- TRELEGY ELLIPTA (Drug) $17.06
- AIRSUPRA (Drug) $14.32
- Rybelsus (Drug) $14.08
- STIOLTO (Drug) $12.04
- Tresiba (Drug) $4.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Schnecksville
Dr. Kenneth Ryder, Md, MD
Family Medicine — Payments: $4,741
Family Medicine $4,741
Dr. Sean Lewis, D.o, D.O
Family Medicine — Payments: $625.97
Family Medicine $625.97
Jeffrey Wells, D.o, D.O
Family Medicine — Payments: $369.89
Family Medicine $369.89
Dr. Susan Kostenblatt, Md, MD
Family Medicine — Payments: $283.90
Family Medicine $283.90
Breanna Henry, Do, DO
Family Medicine — Payments: $115.92
Family Medicine $115.92
Dr. John Farrell, Md, MD
Family Medicine — Payments: $15.26
Family Medicine $15.26